Prevalence of inappropriate use of nirmatrelvir-ritonavir antiviral therapy in hospitalized patients: A multi-centre retrospective study in China

BACKGROUND: Nirmatrelvir-ritonavir (NMVr) is a recently developed antiviral agent for treating coronavirus disease 2019 (COVID-19); however, data describing its appropriate use are scarce. This study examined the prevalence of inappropriate use of NMVr in a Chinese hospital setting. METHODS: A multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Changcheng, Qiu, Lei, Zhuo, Juanjuan, Fang, Yingying, Wang, Limin, Xia, Junbo, Wang, Shuying, Luo, Qing, Zhou, Kang, Li, Yongchen, Li, Qingyu, Wang, Gang, Lin, Nengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197429/
https://www.ncbi.nlm.nih.gov/pubmed/37211263
http://dx.doi.org/10.1016/j.ijantimicag.2023.106857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197429/
https://www.ncbi.nlm.nih.gov/pubmed/37211263
http://dx.doi.org/10.1016/j.ijantimicag.2023.106857

Ejemplares similares